Table 3.
β-Trace Protein (≥0.81 mg/L) | β2-Microglobulin (≥2.80 mg/L) | Standard Cystatin C (≥1.03 mg/L) | |||||||
---|---|---|---|---|---|---|---|---|---|
≥20 yr (n=6682 [1220]) | ≥20 yr (n=6688 [1204]) | ≥20 yr (n=6742 [1680]) | |||||||
OR | 95% CI | P | OR | 95% CI | P | OR | 95% CI | P | |
eGFR creatinine | 0.92 | 0.90–0.93 | <0.01 | 0.92 | 0.91–0.94 | <0.01 | 0.91 | 0.90–0.92 | <0.01 |
BMI (per 5 kg/m2 increase) | 0.80 | 0.68–0.95 | 0.01 | 0.74 | 0.66–0.82 | <0.01 | 1.10 | 0.96–1.26 | 0.15 |
Hypertension | 1.99 | 1.37–2.90 | <0.01 | 1.70 | 1.36–2.14 | <0.01 | 1.71 | 1.18–2.46 | 0.01 |
Diabetes | 1.03 | 0.67–1.59 | 0.88 | 1.51 | 0.92–2.47 | 0.10 | 1.48 | 0.96–2.28 | 0.08 |
Current smoker | 0.89 | 0.55–1.44 | 0.64 | 0.82 | 0.54–1.24 | 0.34 | 1.35 | 0.91–2.01 | 0.13 |
CRP (mg/dl)a | |||||||||
0.22–1.0 | 1.26 | 0.90–1.78 | 0.18 | 1.90 | 1.39–2.59 | <0.01 | 1.11 | 0.85–1.45 | 0.42 |
>1.0 | 2.00 | 1.24–3.25 | 0.01 | 5.70 | 3.52–9.24 | <0.01 | 3.52 | 2.02–6.15 | <0.01 |
Triglycerides (mg/dl) | 0.56 | 0.36–0.88 | 0.01 | 0.75 | 0.55–1.03 | 0.07 | 1.22 | 0.82–1.80 | 0.32 |
HDL (per 10 mg/dl increase) | 0.82 | 0.72–0.94 | <0.01 | 0.80 | 0.71–0.90 | <0.01 | 0.84 | 0.76–0.92 | <0.01 |
Education ≥12 yr | 0.56 | 0.41–0.76 | <0.01 | 0.60 | 0.47–0.77 | <0.01 | 0.59 | 0.46–0.76 | <0.01 |
Numbers in brackets represent individuals with an elevated β-trace protein (≥0.81 mg/L) and elevated β2-microglobulin (≥2.80 mg/L). Triglycerides were analyzed on a logarithmic scale (ln). Triglycerides may be converted from mg/dl to mmol/L by multiplying by 0.0113. HDL may be converted from mg/dl to mmol/L by multiplying by 0.0259. OR, odds ratio; 95% CI, confidence interval; eGFR, estimated GFR; BMI, body mass index; CRP, C-reactive protein.
Reference group is individuals with CRP <0.22 mg/dl.